2B78:XETRA:XETRA-iShares Healthcare Innovation UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 7.036

Change

-0.25 (-3.44)%

Market Cap

USD 1.14B

Volume

0.13M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

ETFs Containing 2B78:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.18% 51% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.18% 50% F 52% F
Trailing 12 Months  
Capital Gain 3.93% 32% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.93% 30% F 36% F
Trailing 5 Years  
Capital Gain 26.71% 49% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.71% 47% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 5.24% 53% F 52% F
Dividend Return 5.24% 52% F 50% F
Total Return N/A 2% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 22.11% 15% F 28% F
Risk Adjusted Return 23.70% 37% F 39% F
Market Capitalization 1.14B 80% B- 71% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.